Now showing items 1-3 of 3

    • Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study 

      Linhares, Alexandre C.; Velázquez, F. Raúl; Pérez Schael, Irene; Sáez Llorens, Xavier; Abate, Héctor; Espinoza, Félix; López, Pío; Macías Parra, Mercedes; Ortega Barría, Eduardo; Rivera Medina, Doris Maribel; Rivera, Luis; Pavia Ruz, Noris; Núñez, Ernesto; Damaso, Silvia; Ruiz Palacios, Guillermo M.; De Vos, Béatrice; O'Ryan Gallardo, Miguel; Gillard, Paul; Bouckenooghe, Alain (ELSEVIER, 2008-04-05)
      Background Peak incidence of rotavirus gastroenteritis is seen in infants between 6 and 24 months of age. We therefore aimed to assess the 2-year efficacy and safety of an oral live attenuated human rotavirus vaccine for ...
    • Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial 

      Asturias, Edwin J.; Bandyopadhyay, Ananda S.; Self, Steve; Rivera, Luis; Sáez Llorens, Xavier; Lopez, Eduardo; Melgar, Mario; Gaensbauer, James T.; Weldon, William C.; Oberste, M. Steven; Borate, Bhavesh R.; Gast, Chris; Clemens, Ralf; Orenstein, Walter; O'Ryan Gallardo, Miguel (Lancet Publishing Group, 2016)
      © 2016 Elsevier Ltd Background Replacement of the trivalent oral poliovirus vaccine (tOPV) with bivalent types 1 and 3 oral poliovirus vaccine (bOPV) and global introduction of inactivated poliovirus vaccine (IPV) are major ...
    • Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis 

      Ruiz Palacios, Guillermo M.; Pérez Schael, Irene; Velázquez, F. Raúl; Abate, Héctor; Breuer, Thomas; Costa Clemens, SueAnn; Cheuvart, Brigitte; Espinoza, Félix; Gillard, Paul; Innis, Bruce L.; Cervantes, Yolanda; Linhares, Alexandre C.; López, Pío; Macías Parra, Mercedes; Ortega Barría, Eduardo; Richardson, Vesta; Rivera Medina, Doris Maribel; Rivera, Luis; Salinas, Belén; Pavia Ruz, Noris; Salmerón, Jorge; Rüttimann, Ricardo; Tinoco, Juan Carlos; Rubio, Pilar; Núñez, Ernesto; Guerrero, Lourdes; Yarzábal, Juan Pablo; Damaso, Silvia; Tornieporth, Nadia; Sáez Llorens, Xavier; Vergara, Rodrigo F.; Vesikari, Timo; Bouckenooghe, Alain; Clemens, Ralf; De Vos, Béatrice; O'Ryan Gallardo, Miguel (Massachusetts Medical Soc, 2006-01-05)
      BACKGROUND: The safety and efficacy of an attenuated G1P[8] human rotavirus (HRV) vaccine were tested in a randomized, double-blind, phase 3 trial. METHODS: We studied 63,225 healthy infants from 11 Latin American ...